dBMEDx news

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with C. R. Bard, a subsidiary of BD (Becton, Dickinson and Company, NYSE: BDX). Under the agreement, Bard/BD will be the exclusive US distributor of the BBS RevolutionTM bladder scanner for the hospital and urology markets.

The dBMEDx BBS RevolutionTM bladder scanner was designed specifically for nurses and utilizes

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with Direct Supply®, the nation’s leading provider of equipment for the Senior Living market. Under the agreement, dBMEDx will integrate their proprietary bladder scanning technology into a new Direct Supply® device to create the first wireless bladder scanner optimized for use in long term care settings.

dBMEDx has developed and patente

dBMEDx was selected as the winner of the 2016 Prime Health Challenge. The company received a $75,000 cash award and was selected by two hospital groups to host a pilot clinical study of the new BBS Revolution™ bladder scanner, which was first launched by the company in 2015.

The BBS RevolutionTM is a next generation bladder scanner that offers nurses, for the first time, a fully automated bladder volume measurement solution. It delivers unparallele

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it was selected  as a finalist in the Prime Health Challenge. dBMEDx is one of six companies chosen to move onto the finals round of this year’s challenge. dBMEDx will compete on stage at the EXDO Event Center in Denver, Colorado to win a share of pilot funding provided by the Colorado Health Foundation.

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received the CE Mark for the BBS Revolution™, a next generation bladder scanner which offers, for the first time, fully automated bladder detection and unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume. This product is currently FDA cleared and is being sold to hospitals and urology offices in the US.

In addition, dBMEDx received ISO 13485 ce